Loring Wolcott & Coolidge Fiduciary Advisors’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $407K | Sell |
940
-140
| -13% | -$42.5K | ﹤0.01% | 249 |
|
|
2026
Q1 | $285K | Sell |
1,080
-40
| -4% | -$8.94K | ﹤0.01% | 285 |
|
|
2025
Q4 | $267K | Buy |
1,120
+500
| +81% | +$77.8K | ﹤0.01% | 288 |
|
|
2025
Q3 | $91.5K | Hold |
620
| – | – | ﹤0.01% | 385 |
|
|
2025
Q2 | $60.4K | Hold |
620
| – | – | ﹤0.01% | 384 |
|
|
2025
Q1 | $41.4K | Hold |
620
| – | – | ﹤0.01% | 392 |
|
|
2024
Q4 | $46.9K | Buy |
+620
| New | +$47K | ﹤0.01% | 395 |
|
|
2024
Q3 | – | Sell |
-620
| Closed | -$66.7K | – | 585 |
|
|
2024
Q2 | $66.7K | Hold |
620
| – | – | ﹤0.01% | 366 |
|
|
2024
Q1 | $53.8K | Buy |
620
+560
| +933% | +$49.3K | ﹤0.01% | 388 |
|
|
2023
Q4 | $4.95K | Hold |
60
| – | – | ﹤0.01% | 522 |
|
|
2023
Q3 | $3.74K | Hold |
60
| – | – | ﹤0.01% | 570 |
|
|
2023
Q2 | $3.86K | Buy |
60
+30
| +100% | +$1.69K | ﹤0.01% | 586 |
|
|
2023
Q1 | $1.59K | Hold |
30
| – | – | ﹤0.01% | 576 |
|
|
2022
Q4 | $1.26K | Sell |
30
-10
| -25% | -$418 | ﹤0.01% | 561 |
|
|
2022
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 593 |
|
|
2022
Q2 | $2K | Sell |
40
-160
| -80% | -$7.62K | ﹤0.01% | 614 |
|
|
2022
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 550 |
|
|
2021
Q4 | $14K | Hold |
200
| – | – | ﹤0.01% | 572 |
|
|
2021
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 578 |
|
|
2021
Q2 | $13K | Buy |
+200
| New | +$12.6K | ﹤0.01% | 583 |
|
|
2021
Q1 | – | Sell |
-70
| Closed | -$3K | – | 536 |
|
|
2020
Q4 | $3K | Hold |
70
| – | – | ﹤0.01% | 729 |
|
|
2020
Q3 | $2K | Hold |
70
| – | – | ﹤0.01% | 571 |
|
|
2020
Q2 | $2K | Hold |
70
| – | – | ﹤0.01% | 565 |
|
|
2020
Q1 | $2K | Hold |
70
| – | – | ﹤0.01% | 616 |
|
|
2019
Q4 | $2K | Hold |
70
| – | – | ﹤0.01% | 649 |
|
|
2019
Q3 | $2K | Sell |
70
-170
| -71% | -$3.57K | ﹤0.01% | 643 |
|
|
2019
Q2 | $5K | Buy |
240
+170
| +243% | +$3.23K | ﹤0.01% | 614 |
|
|
2019
Q1 | $1K | Hold |
70
| – | – | ﹤0.01% | 680 |
|
|
2018
Q4 | $0 | Hold |
70
| – | – | ﹤0.01% | 713 |
|
|
2018
Q3 | $1K | Hold |
70
| – | – | ﹤0.01% | 633 |
|
|
2018
Q2 | $1K | Hold |
70
| – | – | ﹤0.01% | 648 |
|
|
2018
Q1 | $1K | Hold |
70
| – | – | ﹤0.01% | 697 |
|
|
2017
Q4 | $1K | Hold |
70
| – | – | ﹤0.01% | 700 |
|
|
2017
Q3 | $1K | Buy |
+70
| New | +$1.14K | ﹤0.01% | 721 |
|
Other funds holding LRCX
Loring Wolcott & Coolidge Fiduciary Advisors's LRCX Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors reduced its Lam Research (LRCX) stake by 13% in Q2 2026, selling an estimated $42.5K and leaving 940 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #249.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LRCX in Q3 2017 and has held it in 34 quarters since. 1,507 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 940 shares of Lam Research worth $407K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 140 Lam Research shares in Q2 2026, an estimated $42.5K.
- Lam Research made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #249 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Lam Research in Q3 2017 and has held it in 34 quarters since.
- 1,507 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.